Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 4—April 2002
Research

Outcomes of Treated Human Granulocytic Ehrlichiosis Cases

Alan H. Ramsey*†Comments to Author , Edward A. Belongia‡, Craig M. Gale‡, and Jeffrey P. Davis†
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Wisconsin Division of Public Health, Madison, Wisconsin, USA; ‡Marshfield Medical Research Foundation, Marshfield, Wisconsin, USA;

Main Article

Table 1

Recurrent or continuous symptoms experienced during the preceding 12 months by human granulocytic ehrlichiosis patients and controls, Wisconsin, 1999

Symptom Patients (N=85)
number (%) Controls
(N=102)
number (%) OR 95% CI
Fevers 12 (14.1) 3 (2.9) 5.4 1.7-24.4
Shaking chills 16 (18.8) 5 (4.9) 4.5 1.7-14.3
Sweats 31 (36.5) 16 (15.7) 3.1 1.6-6.3
Fatigue 47 (55.3) 38 (37.3) 2.1 1.2-3.7
Confusion 16 (18.8) 12 (11.8) 1.7 0.8-4.0
Muscle weakness 27 (31.8) 30 (29.4) 1.1 0.6-2.1
Headache 21 (24.7) 13 (12.8) 1.1 0.7-1.9
Muscle aches 40 (47.1) 44 (43.1) 1.0 0.7-1.5
Joint pains 50 (58.8) 54 (52.9) 0.9 0.6-1.2
Nausea 14 (16.5) 15 (14.7) 0.8 0.5-1.4

OR = odds ratio; 95% CI = 95% confidence interval.

Main Article

Page created: July 15, 2010
Page updated: July 15, 2010
Page reviewed: July 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external